![]() |
Cancer Reference Information | |||||
|
|
||||||
|
||||||
| Overview: Lymphoma, Non-Hodgkin Type | After the Tests: Staging |
|
Staging is the process of finding out how far the cancer has spread. This is very important because the treatment and the patient's outlook for survival depend on the exact type and stage of the cancer. Tests used to gather information for staging
Ann Arbor Staging System The staging system most often used for NHL is called the Ann Arbor staging system. The stages are described by Roman numerals I through IV (1 through 4). In general, the higher the number, the more serious the cancer. Lymphomas that affect organs outside of the lymph system have E added to their stage (for example, stage IIE), while those affecting the spleen have S added. The letter "B" is added if the person has B symptoms (weight loss, soaking night sweats, or high fever from no known cause). If the person does not have these symptoms the letter "A" is added. The type and stage of the lymphoma give useful information about a person's outlook. But for some types of lymphomas (such as fast-growing ones) the stage is not too helpful on its own. Other factors, called prognostic factors, are looked at to get a better idea of the person's outlook. These factors have proven useful for most types of lymphoma. Prognostic factors An approach called the International Prognostic Index or IPI was put together to help predict how quickly a lymphoma might grow and how well a patient might respond to treatment. Five factors are used to point to a better or worse outcome.
*Serum LDH is a protein found in the blood. LDH goes up when there are fast growing tumors. These factors are important because they allow doctors to plan treatment better than they could if treatment was based only on the type of lymphoma (the pathology report) and staging information. For people with follicular lymphoma, a slightly different set of prognostic factors is used. These are:
*Serum LDH is a protein found in the blood. LDH goes up when there are fast growing tumors. Last Medical Review: 08/06/2009 |